Login / Signup

The Relationship of Continuity of Care, Polypharmacy and Medication Appropriateness: A Systematic Review of Observational Studies.

David LampeJohn GrosserDaniel GensorowskyJulian WitteChristiane MuthMarjan van den AkkerTruc Sophia DinhWolfgang Greiner
Published in: Drugs & aging (2023)
Differences regarding the methodological quality of included studies as well as the heterogeneity in terms of the operationalization and measurement of COC, polypharmacy, and MARO need to be considered when interpreting the results. Yet, our findings suggest that optimizing COC may be helpful in reducing polypharmacy and MARO. Therefore, COC should be acknowledged as an important risk factor for polypharmacy and MARO, and the importance of COC should be considered when designing future interventions targeting these outcomes.
Keyphrases
  • adverse drug
  • healthcare
  • quality improvement
  • physical activity
  • adipose tissue
  • current status
  • pain management
  • cancer therapy
  • metabolic syndrome